U.S. Markets close in 4 hrs, 59 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,002.33 | -56.31 | -0.56% |
| NASDAQ | 2,138.96 | -11.91 | -0.55% |
| S&P 500 | 1,064.11 | -6.41 | -0.60% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 18.89 10:14 AM EST | |
|---|---|---|
| Day High | 19.22 09:32 AM EST |
|
| Range | 0.33 |
| Volume | 121,406 | |
|---|---|---|
| 30-Day Avg Vol | 1.66 M |
|
| Difference | -92.69% |
| Market Cap | 1.91 B | |
|---|---|---|
| Mkt Cap Chg | -19.13 M |
| Shares Out | 100.72 M | |
|---|---|---|
| % Shrs Traded | 0.12% | |
| 1yr EPS Est | 0.064 |
| 52-Wk Low | 9.93 | |
|---|---|---|
| 52-Wk High | 21.50 |
|
| Range | 11.57 |
| Prev Close | 19.17 2/9/10 | |
|---|---|---|
| Today's Open | 19.11 | |
| Change | -0.31% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 10.17 M |
| Revenue (LFY) | 296.49 M | |
|---|---|---|
| Earnings (LFY) | 30.83 M | |
| Earnings (MRQ) | 6.64 M | |
| Next Earn Est | 0.012 | |
| Next Earnings | 04/30/2010 |
|
| EPS (TTM) | 0.16 | |
| 1yr EPS Growth | -57.33% |
| P/E Ratio (TTM) | 46.29 | |
|---|---|---|
| P/E Ratio (Fwd) | 296.00 | |
| PEG Ratio | 12.16 | |
| Return on Equity | 12.74 | |
| Beta | 1.37 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
BioMarin Pharmaceuticals works to raise orphan drugs up right. The company has developed three FDA-approved drugs that qualify for orphan drug status, a financial incentive that encourages companies to ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | 0.012 2/23/10 | — — |
—
—
|
| Last Quarter | 0.006 9/30/09 | 0.06 9/30/09 |
0.054
Beat
|
| 2 Quarters Ago | -0.012 6/30/09 | 0.01 6/30/09 |
0.022
Beat
|
| Quarterly - 09/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 81.54 M | 296.49 M |
| Gross Profit | 66.52 M | 239.61 M |
| Operating Income | 1.18 M | 39.76 M |
| Net Income | 6.64 M | 30.83 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts